These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4190784)

  • 1. [Inactivation of tissue-specific inhibitors by a carcinogen].
    Volm M; Kinzel V; Süss R
    Verh Dtsch Ges Pathol; 1969; 53():560-4. PubMed ID: 4190784
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of chemical modification of ribonucleic acid transport by liver carcinogens in the rat.
    Shearer RW
    Biochemistry; 1974 Apr; 13(8):1764-7. PubMed ID: 4364710
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavior of opposing pathways of thymidine utilization in differentiating, regenerating, and neoplastic liver.
    Ferdinandus JA; Morris HP; Weber G
    Cancer Res; 1971 May; 31(5):550-6. PubMed ID: 4325837
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA synthesis in Morris hepatoma 9618A and in host liver following partial hepatectomy in rats adapted to controlled feeding schedules.
    Barbiroli B; Potter VR; Morris HP
    Cancer Res; 1972 Jan; 32(1):7-10. PubMed ID: 4332475
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of the inhibition of DNA synthesis by deoxyadenosine in tumor cells].
    Vornovitskaia GI; Ol'shanetskaia AD; Novikova MA; Karelina LP; Morozova NS
    Biokhimiia; 1972; 37(5):940-7. PubMed ID: 4344203
    [No Abstract]   [Full Text] [Related]  

  • 6. The content of the principal protein target of a hepatic carcinogen in liver tumors.
    Mott DM; Sani BP; Sorof S
    Cancer Res; 1973 Nov; 33(11):2721-5. PubMed ID: 4355980
    [No Abstract]   [Full Text] [Related]  

  • 7. A growth regulating factor in rat liver.
    Otsuka H
    Wistar Inst Symp Monogr; 1967; 7():3-13. PubMed ID: 4296793
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of the cell-sap factor inhibiting DNA synthesis of rat ascites hepatoma cells in normal tissues, various malignant and minimal deviation hepatomas, as well as livers during the course of carcinogenesis.
    Terayama H; Sasada M
    Gan; 1968 Feb; 59(1):51-9. PubMed ID: 4298975
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation by chemical carcinogens of gamma-glutamyl transpeptidase in rat and mouse liver.
    Fiala S; Fiala ES
    J Natl Cancer Inst; 1973 Jul; 51(1):151-8. PubMed ID: 4146459
    [No Abstract]   [Full Text] [Related]  

  • 10. Competitive RNA-DNA hybridization of nuclear and microsomal RNA during diethylnitrosamine hepatocarcinogenesis.
    Garrett CT; Katz C; Moore RE; Pitot HC
    Cancer Res; 1973 Jul; 33(7):1662-9. PubMed ID: 4352795
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic carcinogenesis.
    Farber E
    Prog Liver Dis; 1972; 4():173-82. PubMed ID: 4119891
    [No Abstract]   [Full Text] [Related]  

  • 12. The stimulatory effect of a serum factor on DNA and protein synthesis in hepatoma cells.
    Dolan ML; Coetzee ML; Spangler M; Ove P
    Cancer Res; 1974 Nov; 34(11):3010-7. PubMed ID: 4371609
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-four-hour variations in DNA synthesis of a fast-growing and a slow-growing hepatoma: DNA synthesis rhythm in hepatoma.
    Nash RE; Llanos JM
    J Natl Cancer Inst; 1971 Nov; 47(5):1007-12. PubMed ID: 4330794
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electron microscopic changes in toxically injured and proliferating liver cells due to long-term application of diethylnitrosamine].
    Bader G; Stiller D; Ullrich K
    Arch Geschwulstforsch; 1971; 37(4):327-43. PubMed ID: 4330774
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma protein synthesis by N-2-fluorenylacetamide-induced primary hepatocellular carcinomas and hepatic nodules.
    Becker FF; Klein KM; Asofsky R
    Cancer Res; 1972 May; 32(5):914-20. PubMed ID: 4336030
    [No Abstract]   [Full Text] [Related]  

  • 16. The metabolism of 4-nitroquinoline-1-oxide, a carcinogen. 3. An enzyme catalyzing the conversion of 4-nitroquinoline-1-oxide to 4-hydroxyaminoquinoline-1-oxide in rat liver and hepatomas.
    Sugimura T; Okabe K; Nagao M
    Cancer Res; 1966 Aug; 26(8):1717-21. PubMed ID: 4288552
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of crystalline ricin on the biosynthesis of protein, RNA, and DNA in experimental tumor cells.
    Lin JY; Liu K; Chen CC; Tung TC
    Cancer Res; 1971 Jul; 31(7):921-4. PubMed ID: 4327085
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 20. Early events during liver carcinogenesis involving two carcinogen:protein complexes.
    Blackburn GR; Andrews JP; Custer RP; Sorof S
    Cancer Res; 1981 Oct; 41(10):4039-49. PubMed ID: 6269733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.